Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 38.40
+0.40 (1.05%)
Apr 28, 2026, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.96 billion as of April 28, 2026. Its market cap has decreased by -25.25% in one year.
Market Cap
4.96B
Enterprise Value
3.93B
Revenue
67.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.40
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 4.96B, an increase of 2.09%. That is a compound annual growth rate of 0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 4.91B | -26.74% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UnicoCell Biomed | 5.14B |
| Steminent Biotherapeutics | 5.20B |
| Senhwa Biosciences | 4.55B |
| Medigen Biotechnology | 4.44B |
| Panion & Bf Biotech | 5.43B |
| ACRO Biomedical | 4.29B |
| OBI Pharma | 4.14B |
| Formosa Pharmaceuticals | 4.11B |